A novel mutation in DDR2 causing spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking

BMC Medical Genetics

Bassam R Ali⁵  Birgit Leitinger²  Lihadh Al-Gazali¹  Lamya Al-Anbouri³  Maha Al-Awadi³  Anuradha Ganesh⁴  Abeer Al Sayegh³  Anne John⁵  Huifang Xu²  Praseetha Kizhakkedath⁵  Adila Al-Kindi³ 

[1] Department of Paediatrics, College of Medicine and Heath Sciences, United Arab Emirates University, Al Ain, United Arab Emirates;National Heart and Lung Institute, Imperial College London, London SW7 2AZ, United Kingdom;Department of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University, Al koudh, 123, Muscat Sultanate of Oman;Pediatric Ophthalmology, Sultan Qaboos University Hospital, Sultan Qaboos University, Alkoudh, 123, Muscat, Sultanate of Oman;Department of Pathology, College of Medicine and Heath Sciences, United Arab Emirates University, P.O. Box 17666 Al Ain, United Arab Emirates

关键词: Optic atrophy;    ERAD;    SMED-SL;    Trafficking defect;    Spondylo-meta-epiphyseal dysplasia;    DDR2;   

Others  :  1092137
DOI  :  10.1186/1471-2350-15-42

 received in 2014-03-16, accepted in 2014-04-04,  发布年份 2014

【 摘 要 】

Background

The rare autosomal genetic disorder, Spondylo-meta-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL), is reported to be caused by missense or splice site mutations in the human discoidin domain receptor 2 (DDR2) gene. Previously our group has established that trafficking defects and loss of ligand binding are the underlying cellular mechanisms of several SMED-SL causing mutations. Here we report the clinical characteristics of two siblings of consanguineous marriage with suspected SMED-SL and identification of a novel disease-causing mutation in the DDR2 gene.

Methods

Clinical evaluation and radiography were performed to evaluate the patients. All the coding exons and splice sites of the DDR2 gene were sequenced by Sanger sequencing. Subcellular localization of the mutated DDR2 protein was determined by confocal microscopy, deglycosylation assay and Western blotting. DDR2 activity was measured by collagen activation and Western analysis.

Results

In addition to the typical features of SMED-SL, one of the patients has an eye phenotype including visual impairment due to optic atrophy. DNA sequencing revealed a novel homozygous dinucleotide deletion mutation (c.2468_2469delCT) on exon 18 of the DDR2 gene in both patients. The mutation resulted in a frameshift leading to an amino acid change at position S823 and a predicted premature termination of translation (p.S823Cfs*2). Subcellular localization of the mutant protein was analyzed in mammalian cell lines, and it was found to be largely retained in the endoplasmic reticulum (ER), which was further supported by its N-glycosylation profile. In keeping with its cellular mis-localization, the mutant protein was found to be deficient in collagen-induced receptor activation, suggesting protein trafficking defects as the major cellular mechanism underlying the loss of DDR2 function in our patients.

Conclusions

Our results indicate that the novel mutation results in defective trafficking of the DDR2 protein leading to loss of function and disease. This confirms our previous findings that DDR2 missense mutations occurring at the kinase domain result in retention of the mutant protein in the ER.

【 授权许可】

   
2014 Al-Kindi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Borochowitz Z, Langer LO Jr, Gruber HE, Lachman R, Katznelson MB, Rimoin DL: Spondylo-meta-epiphyseal dysplasia (SMED), short limb-hand type: a congenital familial skeletal dysplasia with distinctive features and histopathology. Am J Med Genet 1993, 45:320-326.
• [2]Langer LO Jr, Wolfson BJ, Scott CI Jr, Reid CS, Schidlow DV, Millar EA, Borns PF, Lubicky JP, Carpenter BL: Further delineation of spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type, with emphasis on diagnostic features. Am J Med Genet 1993, 45:488-500.
• [3]Smithson SF, Grier D, Hall CM: Spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type. Clin Dysmorphol 2009, 18:31-35.
• [4]Al-Gazali LI, Bakalinova D, Sztriha L: Spondylo-meta-epiphyseal dysplasia, short limb, abnormal calcification type. Clin Dysmorphol 1996, 5:197-206.
• [5]Dias C, Cairns R, Patel MS: Sudden death in spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type. Clin Dysmorphol 2009, 18:25-29.
• [6]Bargal R, Cormier-Daire V, Ben-Neriah Z, Le Merrer M, Sosna J, Melki J, Zangen DH, Smithson SF, Borochowitz Z, Belostotsky R, Raas-Rothschild A: Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications. Am J Hum Genet 2009, 84:80-84.
• [7]Ali BR, Xu H, Akawi NA, John A, Karuvantevida NS, Langer R, Al-Gazali L, Leitinger B: Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Hum Mol Genet 2010, 19:2239-2250.
• [8]Vogel W, Gish GD, Alves F, Pawson T: The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1997, 1:13-23.
• [9]Shrivastava A, Radziejewski C, Campbell E, Kovac L, McGlynn M, Ryan TE, Davis S, Goldfarb MP, Glass DJ, Lemke G, Yancopoulos GD: An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Mol Cell 1997, 1:25-34.
• [10]Vogel WF, Abdulhussein R, Ford CE: Sensing extracellular matrix: an update on discoidin domain receptor function. Cell Signal 2006, 18:1108-1116.
• [11]Leitinger B: Transmembrane collagen receptors. Annu Rev Cell Dev Biol 2011, 27:265-290.
• [12]Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R: Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev 2012, 31:295-321.
• [13]Leitinger B, Kwan AP: The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biol 2006, 25:355-364.
• [14]Xu L, Peng H, Wu D, Hu K, Goldring MB, Olsen BR, Li Y: Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 2005, 280:548-555.
• [15]Olaso E, Labrador JP, Wang L, Ikeda K, Eng FJ, Klein R, Lovett DH, Lin HC, Friedman SL: Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. J Biol Chem 2002, 277:3606-3613.
• [16]Flynn LA, Blissett AR, Calomeni EP, Agarwal G: Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. J Mol Biol 2010, 395:533-543.
• [17]Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, Manes S, Bruckner K, Goergen JL, Lemke G, Yancopoulos G, Angel P, Martinez C, Klein R: The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2001, 2:446-452.
• [18]Kano K, Marin de Evsikova C, Young J, Wnek C, Maddatu TP, Nishina PM, Naggert JK: A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Mol Endocrinol 2008, 22:1866-1880.
• [19]Kano K, Kitamura A, Matsuwaki T, Morimatsu M, Naito K: Discoidin domain receptor 2 (DDR2) is required for maintenance of spermatogenesis in male mice. Mol Reprod Dev 2010, 77:29-37.
• [20]Matsumura H, Kano K, Marin De Evsikova C, Young JA, Nishina PM, Naggert JK, Naito K: Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function. Physiol Genomics 2009, 39:120-129.
• [21]Carafoli F, Hohenester E: Collagen recognition and transmembrane signalling by discoidin domain receptors. Biochim Biophys Acta 1834, 2013:2187-2194.
• [22]Leitinger B: Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2: identification of collagen binding sites in DDR2. J Biol Chem 2003, 278:16761-16769.
• [23]Carafoli F, Mayer MC, Shiraishi K, Pecheva MA, Chan LY, Nan R, Leitinger B, Hohenester E: Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling. Structure 2012, 20:688-697.
• [24]Mihai C, Chotani M, Elton TS, Agarwal G: Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. J Mol Biol 2009, 385:432-445.
• [25]Noordeen NA, Carafoli F, Hohenester E, Horton MA, Leitinger B: A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. J Biol Chem 2006, 281:22744-22751.
• [26]Carafoli F, Bihan D, Stathopoulos S, Konitsiotis AD, Kvansakul M, Farndale RW, Leitinger B, Hohenester E: Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure 2009, 17:1573-1581.
• [27]Zhang Y, Su J, Yu J, Bu X, Ren T, Liu X, Yao L: An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. J Bone Miner Res 2011, 26:604-617.
• [28]Lin KL, Chou CH, Hsieh SC, Hwa SY, Lee MT, Wang FF: Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. J Bone Miner Res 2010, 25:2489-2503.
• [29]Khosravi R, Sodek KL, Faibish M, Trackman PC: Collagen advanced glycation inhibits its discoidin domain receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts. Bone 2014, 58:33-41.
• [30]Gualeni B, Rajpar MH, Kellogg A, Bell PA, Arvan P, Boot-Handford RP, Briggs MD: A novel transgenic mouse model of growth plate dysplasia reveals that decreased chondrocyte proliferation due to chronic ER stress is a key factor in reduced bone growth. Dis Model Mech 2013, 6(6):1414-25.
• [31]Chen Y, Bellamy WP, Seabra MC, Field MC, Ali BR: ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including robinow syndrome. Hum Mol Genet 2005, 14:2559-2569.
• [32]Ali BR, Jeffery S, Patel N, Tinworth LE, Meguid N, Patton MA, Afzal AR: Novel robinow syndrome causing mutations in the proximal region of the frizzled-like domain of ROR2 are retained in the endoplasmic reticulum. Hum Genet 2007, 122:389-395.
• [33]Hume AN, Buttgereit J, Al-Awadhi AM, Al-Suwaidi SS, John A, Bader M, Seabra MC, Al-Gazali L, Ali BR: Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type maroteaux. Hum Mol Genet 2009, 18:267-277.
• [34]McCracken AA, Brodsky JL: Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays 2003, 25:868-877.
• [35]Aridor M, Hannan LA: Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic 2000, 1:836-851.
• [36]Aridor M, Hannan LA: Traffic jams II: an update of diseases of intracellular transport. Traffic 2002, 3:781-790.
• [37]Guerriero CJ, Brodsky JL: The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology. Physiol Rev 2012, 92:537-576.
• [38]Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE: Nonsense-mediated decay approaches the clinic. Nat Genet 2004, 36:801-808.
• [39]Konitsiotis AD, Raynal N, Bihan D, Hohenester E, Farndale RW, Leitinger B: Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. J Biol Chem 2008, 283:6861-6868.
• [40]Phan TN, Wong EL, Sun X, Kim G, Jung SH, Yoon CN, Yang BS: Low stability and a conserved N-glycosylation site are associated with regulation of the discoidin domain receptor family by glucose via post-translational N-glycosylation. Biosci Biotechnol Biochem 2013, 77:1907-1916.
• [41]Mohan RR, Wilson SE: Discoidin domain receptor (DDR) 1 and 2: collagen-activated tyrosine kinase receptors in the cornea. Exp Eye Res 2001, 72:87-92.
• [42]Isidor B, Lindenbaum P, Pichon O, Bezieau S, Dina C, Jacquemont S, Martin-Coignard D, Thauvin-Robinet C, Le Merrer M, Mandel JL, David A, Faivre L, Cormier-Daire V, Redon R, Le Caignec C: Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis. Nat Genet 2011, 43:306-308.
• [43]Alves F, Saupe S, Ledwon M, Schaub F, Hiddemann W, Vogel WF: Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: differential expression in human colon cancer cell lines. FASEB J 2001, 15:1321-1323.
• [44]Lemmon MA, Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell 2010, 141:1117-1134.
• [45]Leitinger B: Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol 2014, 310:39-87.
• [46]Ali BR: Is cystic fibrosis-related diabetes an apoptotic consequence of ER stress in pancreatic cells? Med Hypotheses 2009, 72:55-57.